Chiropractors in Rockmart, GA Accepting Medicare

5 Chiropractors found. Showing 1 - 5

Mitchell Chiropractic & Wellness Chiropractor Medicare: Medicare Enrolled Practice Location: 111 Felton Dr, Rockmart, GA 30153 Phone: 770-324-3075

Dr. Andrew N Kondyles, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 614 E Elm St, Rockmart, GA 30153 Phone: 770-684-1024    Fax: 770-684-1026

Rockmart Family Chiropractic, P.c. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 100 S Marble St, Rockmart, GA 30153 Phone: 678-757-8001

Dr. Jonathan David Goldberg, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 100 S Marble St, Rockmart, GA 30153 Phone: 678-757-8001    Fax: 678-757-8002

Dr. Douglas Nathan Mitchell, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 111 Felton Dr, Rockmart, GA 30153 Phone: 770-684-4963

News Archive

Scientists uncover potential drug target for effective therapy against bacterial disease brucellosis

UC Davis scientists have uncovered a potential drug target for the development of an effective therapy against the debilitating, chronic form of the bacterial disease brucellosis, which primarily afflicts people in Mediterranean and Middle Eastern countries.

FDA approves Abbott's CREON sNDA including dosing guidance for treating EPI due to CP, pancreatectomy

Abbott announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for CREON® (pancrelipase) Delayed-Release Capsules that now includes dosing guidance in the prescribing information specific to patients with limited production of enzymes in the pancreas (exocrine pancreatic insufficiency) due to chronic pancreatitis (CP) or removal of the pancreas (pancreatectomy). Prior to this FDA approval, dosing guidance for medications such as CREON was based on patients with cystic fibrosis.

Findings may help doctors recommend appropriate treatments, improve patient outcomes

Like a car's front and back bumpers, your cell's chromosomes are capped by "telomeres" that protect this genetic material against deterioration. Still, after enough replications, a chromosome's telomeres break down and once they reach a certain point of degradation, the cell dies. This is one reason that cells are mortal: telomeres only last so long. That is, unless the enzyme telomerase builds new material onto the worn telomeres to reinforce these chromosomal "bumpers". Telomere repair can be a good thing, but in some cases it's not: overactive telomerase can lengthen telomeres until a cell becomes immortal…leading to cancer.

Cylene Pharmaceuticals to present data on CK2 inhibitor at ASH Annual Meeting

Cylene Pharmaceuticals, Inc. has been selected to present data describing the activity of their first-in-class CK2 inhibitor at the 52nd Annual Meeting of the American Society of Hematology, to be held on December 4-7 in Orlando, FL, the company announced today. Kenna Anderes, VP Cancer Biology at Cylene, will discuss research on targeting CK2, a protein kinase that is essential for the progression of multiple myeloma but that has not been previously exploited as an anticancer target.

Noscira receives FDA approval for Tideglusib drug to treat PSP

Noscira, a Grupo Zeltia subsidiary specialized in research and development of drugs to treat neurodegenerative diseases, has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track status to its neuroprotector drug Tideglusib (ZentylorTM) to treat Progressive Supranuclear Palsy (PSP), a fast-advancing fatal degenerative brain disorder.

Read more Medical News

› Verified 5 days ago